CHYM · Chime Financial, Inc.

Current Thesis

Chime Financial's earnings re-rating now includes the proposed Stride acquisition; delivery against September's higher revenue outlook and a recovery above the market's September 18 reference high would confirm the case. The September 8 announcement supersedes the earlier expectation of a quiet interval between earnings: Chime agreed to acquire Stride for $590 million in cash and raised its revenue outlook. September 8 announcement

The interpretation is that the narrative is maturing — analyst targets rose together on September 9, but the September 18 adjusted close of $30.33 was below the September 4 close of $33.76. The operating outlook has improved while price confirmation has weakened. The case requires reported Q3 revenue of at least $705 million and a weekly close above $34.55, the supplied September 18 52-week high, before the published invalidation occurs.

Bullish and bearish views on Chime Financial, Inc.

The model's bull view on Chime Financial, Inc. (CHYM), in brief: The revenue hurdle moved higher. On September 8, 2026, Chime forecast Q3 revenue of $705 million and full-year revenue of $2.76–2.77 billion, replacing the August 5 forecasts of $680–690 million and $2.725–2.745 billion. These are management forecasts, not reported results.… The bear view: These are third-party transactions, and the filing establishes continued supply without establishing why the seller acted or whether it caused the subsequent decline. Both cases follow in full.

Bull Case

• The revenue hurdle moved higher. On September 8, 2026, Chime forecast Q3 revenue of $705 million and full-year revenue of $2.76–2.77 billion, replacing the August 5 forecasts of $680–690 million and $2.725–2.745 billion. These are management forecasts, not reported results. September 8 release
• Profitability has reported support. The August 5 Q2 release reported revenue of $669.8 million, up 27% year over year, and net income under generally accepted accounting principles of $28 million. Active members reached 10.4 million, up 20% year over year. Q2 results
• Bank ownership adds an economic claim. Management's September 8 announcement projects more than $100 million in net synergies through bank-fee savings, lending expansion and lower funding costs. Those benefits remain prospective; transaction termination or withdrawal of that projection would remove this leg. Acquisition announcement

Bear Case

• These are third-party transactions, and the filing establishes continued supply without establishing why the seller acted or whether it caused the subsequent decline. DST Form 4
• Sequential profitability had already softened. The August 5 results showed adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) of $102 million at a 15% margin, versus Q1's $119 million and 18%. Revenue growth alone therefore does not establish improving sequential profitability. Q2 results
• The transaction remains conditional. On September 8, management anticipated completion in the first half of 2027, subject to regulatory approvals. The acquisition filing identifies approval conditions and integration costs as risks; agreement signing does not establish realized savings. Announcement, transaction filing

Setup & Price Structure

The measured September 18, 2026 adjusted close was $30.33, with a three-month price increase of 79.3% and a 12.2% gap below the supplied 52-week high of $34.55. The 14-period relative strength index was 39.9. These observations describe a strong trailing advance with weaker recent momentum; they do not establish a completed base.

The September 9 Benzinga analyst-action headlines clustered around the announcement: Morgan Stanley and Piper Sandler raised their targets to $40, Evercore ISI to $42, and Canaccord Genuity to $50. Against those dated revisions, the September 18 close documents a failure to sustain the earlier September 4 close of $33.76. Analyst attention is observable; retail participation, short-interest crowding and distance above a rising moving average are not established by the available evidence.

The $27 June 2025 initial public offering (IPO) price provides the thesis boundary. It is a documented public reference, not evidence of a recently tested support shelf. A weekly close below $27 would end the recovery-above-IPO interpretation; the distant $15.88 threshold in earlier coverage no longer describes this narrower case.

Catalyst Calendar (next 30 days)

• 2026-09-30 — Q3 quarter-end. This closes the reporting period covered by the September 8 guidance increase. It is a measurement boundary, not a scheduled earnings release.
• ~2026-11-03, estimated — Q3 results. The previously published estimate remains unconfirmed. This later event matters because reported revenue can be compared with management's September outlook; it is not a company-announced appointment.

As reviewed on September 19, Chime's investor calendar lists no upcoming events and places the September 9 conference appearance among past events. No confirmed disclosure catalyst is identified within the next 30 days. Company event calendar

What Would Change Our Mind

Loss of the recovery above Chime's June 2025 IPO price would break the market-structure case: a weekly close below $27 is the observable invalidation. Operationally, Q3 revenue below the September 8 forecast of $705 million would contradict the acceleration case even if that price condition had not occurred.

Confirmation requires both delivery against that revenue forecast and a weekly close above the September 18 reference high of $34.55 before invalidation. The evidence supports medium conviction: the forecast has improved, but September 14 disclosed supply and the September 18 price retreat prevent the operating revision from serving as price confirmation.

Correlation Notes

This is a single-name case centered on Chime's September 8 guidance and acquisition announcement. The September 15 headline comparing Dave, Visa and Chime supplies a peer comparison, not a measured return correlation. No paired return series is available here, so the evidence supports no numerical correlation claim or conclusion that a broader fintech advance will carry Chime. Its own revenue delivery and published close conditions remain the tests.